EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interaction Between α-Synuclein and DJ-1 in Parkinson’s Disease

Pouya Sobhifar, David R Brown iD

Brain Sciences · 22.08.2025 · 15 (9) · 899

DOI: 10.3390/brainsci15090899 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 22.08.2025. Verfasst von Pouya Sobhifar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Bath, Bath BA2 7AY, UK. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders among the elderly. The exact etiology of sporadic PD is still unknown; however, there is general consensus that the accumulation and aggregation of α-synuclein (α-syn) are among the prominent pathological features. The precise function of α-syn in the healthy human brain is not agreed upon, although it has been reported to play a role in vesicular trafficking and neurotransmitter release. Dutch Juvenile-1 (DJ-1) is a multifunctional protein involved in regulating an array of mechanisms, including oxidative stress, ferroptosis, mitochondrial and dopamine homeostasis. Loss-of-function of DJ-1 was reported to cause familial PD, and oxidative inactivation of DJ-1 has been observed in sporadic cases, suggesting that both genetic and post-translational events converge on common disease pathways. This review proposes that loss of DJ-1 function may elevate intracellular α-syn levels, leading to their aggregation and consequent neurotoxicity. Reports suggest that DJ-1 can inhibit α-syn aggregation, facilitate α-syn clearance via chaperone-mediated autophagy, and act as a deglycase or glyoxalase to neutralize glycated α-syn species. Clinical studies have also reported altered DJ-1 oxidation states in PD patient samples, supporting its potential as a biomarker. By bridging familial and sporadic PD mechanisms, DJ-1 emerges as a compelling therapeutic target with the potential to mitigate α-syn–mediated neurodegeneration across both forms. However, further research is required to fully establish its clinical relevance and translational potential.

Schlagwörter

Stichwörter der Autor:innen

DJ-1Parkinson’s diseaseaggregationglycationα-synuclein

Autor:innen und Institutionen

  • Department of Life Sciences, University of Bath, Bath BA2 7AY, UK.

ORCID-Profile: David R Brown

Zitieren

APA

Sobhifar, P., & Brown, D. R. (2025). Interaction Between α-Synuclein and DJ-1 in Parkinson’s Disease. Brain Sciences, 15(9), 899. https://doi.org/10.3390/brainsci15090899

Vancouver

Sobhifar P, Brown DR. Interaction Between α-Synuclein and DJ-1 in Parkinson’s Disease. Brain Sciences. 2025;15(9):899. doi:10.3390/brainsci15090899

BibTeX
@article{Sobhifar2025,
  author = {Sobhifar, Pouya and Brown, David R},
  title = {Interaction Between α-Synuclein and DJ-1 in Parkinson’s Disease},
  journal = {Brain Sciences},
  year = {2025},
  volume = {15},
  number = {9},
  pages = {899},
  doi = {10.3390/brainsci15090899}
}
Kostenlos starten →